Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
175.41 USD163.95 USD205.57 USD
+17.87%
163.95 USDCurrent price is 17.9% above the base model value.
B
US
BIIB.US · BIOGEN INC.
US · US
Latest price193.25 USD
30D-13.15%
Vs. base value+14%
Research summary
BIIB.US latest organized financial period shows revenue grew +2.22% YoY and net income declined -20.79% YoY. Current price is about 193 USD, while the model base case is about 170 USD; the current price sits +14% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue10B USD
Net income1B USD
Free cash flow2B USD
Operating cash flow2B USD
Price trend
Price date: 2026/04/29 · Updated: 2026/04/29 15:24
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price193.25 USD
Base value169.53 USD
Vs. base+14%
Price date2026/04/29
175.41 USD169.53 USD205.57 USD
+13.99%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
191.56 USD269.36 USD325.36 USD
-28.26%
269.36 USDCurrent price is 28.3% below the base model value.Adjusted reference: 128.58 USD
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth0.2%
Current price implies roughly 0.2% annualized FCF growth.
0.2%Current price implies roughly 0.2% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
169.53 USD169.53 USD169.53 USD
+13.99%
169.53 USDCurrent price is 14% above the base model value.
Updated: 2026/04/29 15:24
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Litigation settlement | Litigation | -110M USD | Medium |
| 2025/12/31 | Restructuring charges | Restructuring | -38M USD | Medium |
| 2024/12/31 | Litigation settlement | Litigation | -21M USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -48M USD | Medium |
| 2023/12/31 | Litigation settlement | Litigation | -3M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -519M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | 1B USD | Medium |
| 2022/12/31 | Litigation settlement | Litigation | -2B USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -311M USD | Medium |
| 2026/03/31 | Litigation settlement | Litigation | -4M USD | Medium |
| 2026/03/31 | Restructuring charges | Restructuring | -6M USD | Medium |
| 2025/09/30 | Restructuring charges | Restructuring | -39M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -28M USD | Medium |
| 2025/03/31 | Litigation settlement | Litigation | -2M USD | Medium |
| 2025/03/31 | Restructuring charges | Restructuring | -56M USD | Medium |
| 2024/09/30 | Asset sale gain/loss | Asset sale gain/loss | 140M USD | Medium |
| 2024/09/30 | Restructuring charges | Restructuring | -50M USD | Medium |
| 2024/06/30 | Asset sale gain/loss | Asset sale gain/loss | 140M USD | Medium |
| 2024/06/30 | Restructuring charges | Restructuring | -39M USD | Medium |
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 13
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 10B USD | 1B USD | 1B USD | 2B USD | 8.79 | 9.8 |
| 2024/12/31 | Annual | 10B USD | 2B USD | 2B USD | 3B USD | 11.18 | 11.65 |
| 2023/12/31 | Annual | 10B USD | 1B USD | 2B USD | 1B USD | 7.97 | 11.55 |
| 2022/12/31 | Annual | 10B USD | 3B USD | 4B USD | 1B USD | 20.87 | 29.71 |
| 2021/12/31 | Annual | 11B USD | 2B USD | - | 3B USD | 10.4 | - |
Ad placement